Long-Term Outcomes of Induction Therapies with Alemtuzumab, Basiliximab or Methylprednisolone in Kidney Transplant Patients with Delayed Graft Function
2013 ◽
Vol 11
(4)
◽
pp. 310-314
◽
2006 ◽
Vol 38
(10)
◽
pp. 3479-3482
◽
2018 ◽
Vol 49
(2)
◽
pp. 101-108
◽
2003 ◽
Vol 35
(5)
◽
pp. 1655-1657
◽